Among active 13F managers last quarter, 3 opened and 1 added, while none reduced or exited; the largest holder to move was Armistice Capital, LLC (new position). No open-market insider trades in the last 180 days.
Funds lean in and no leg opposes.
14 tracked 13F filers disclose a position in GOVX as of the latest SEC 13F filings, a combined $438K in reported value. Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.
| # | Fund | Shares | Position value | Last move | As of | History |
|---|---|---|---|---|---|---|
| 1 | Armistice Capital, LLC | 269K | $372K | ▲New +269K sh | Q1 2026 | |
| 2 | Geode Capital Management, LLC | 21K | $27K | ▼−41% Reduced · −15K sh | Q2 2026 | |
| 3 | Two Sigma Securities, LLC | 11K | $14K | ▲New +11K sh | Q2 2026 | |
| 4 | Vanguard Fiduciary Trust Co | 5K | $6K | —Held | Q2 2026 | |
| 5 | UBS Group AG | 4K | $6K | ▼−95% Reduced · −85K sh | Q1 2026 | |
| 6 | Tower Research Capital LLC (TRC) | 4K | $5K | ▲New +4K sh | Q1 2026 | |
| 7 | Vanguard Capital Management LLC | 3K | $4K | —Held | Q2 2026 | |
| 8 | SBI Securities Co., Ltd. | 3K | $3K | ▲+574% Added · +2K sh | Q2 2026 | |
| 9 | BlackRock, Inc. | 842 | $1K | ▼−23% Reduced · −251 sh | Q2 2026 | |
| 10 | Wells Fargo & Company | 31 | $43 | ▼−88% Reduced · −219 sh | Q1 2026 | |
| 11 | Morgan Stanley | 6 | $8 | ▼−95% Reduced · −114 sh | Q1 2026 | |
| 12 | Danske Bank A/s | 3 | $4 | —Held | Q2 2026 | |
| 13 | FMR LLC | 1 | $1 | —Held | Q2 2026 | |
| 14 | Royal Bank Of Canada | 1 | $0 | ▼−75% Reduced · −3 sh | Q1 2026 |
Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.
Last quarter, 3 funds opened a new position in GOVX and 1 added to an existing one, while none reduced or exited. Based on 13F filings from active, signal-eligible managers (passive index funds and other mechanical holders are excluded from this count).
| Company | Co-held by | Their position there |
|---|---|---|
| Nvidia CorpNVDA | 4 funds | $550.8M |
| Micron Technology IncMU | 4 funds | $228.7M |
| Alphabet Inc-CL AGOOGL | 4 funds | $193.0M |
| Microsoft CorpMSFT | 4 funds | $188.1M |
| PTC Therapeutics IncPTCT | 4 funds | $142.1M |
| Madrigal Pharmaceuticals IncMDGL | 4 funds | $140.5M |
| Meta Platforms Inc-Class AMETA | 4 funds | $75.5M |
| Incyte CorpINCY | 4 funds | $62.4M |
| Advanced Micro DevicesAMD | 4 funds | $58.4M |
| Dyne Therapeutics IncDYN | 4 funds | $58.0M |
| Sandisk CorpSNDK | 4 funds | $53.3M |
| Ironwood Pharmaceuticals IncIRWD | 4 funds | $52.8M |
Ranked by how many of GOVX's tracked holders also hold each name. The last column is those co-holders' combined reported position in that name, not in GOVX.
| Date | Insider | Role | Action | Shares | Value |
|---|---|---|---|---|---|
| Oct 17, 2025 | Spencer John N Jr | Director | Buy (P) | 10K | $6K |
| Aug 7, 2025 | McKee Kelly T. Jr. | Chief Medical Officer | Buy (P) | 1K | $742 |
| Apr 10, 2025 | Spencer John N Jr | Director | Buy (P) | 10K | $10K |
| Apr 10, 2025 | Sharkey John W. | VP, Business Development | Buy (P) | 6K | $6K |
| Apr 1, 2025 | Dodd David A | President, CEO, Director | Buy (P) | 10K | $11K |
| Mar 31, 2025 | Reynolds Mark | CFO | Buy (P) | 7K | $7K |
| Aug 9, 2024 | Dodd David A | President, CEO, Director | Buy (P) | 8K | $16K |
| Feb 22, 2024 | Dodd David A | President, CEO, Director | Buy (P) | 8K | $19K |
| Feb 21, 2024 | Dodd David A | President, CEO, Director | Buy (P) | 520 | $1K |
| Feb 7, 2024 | Reynolds Mark | CFO | Buy (P) | 2K | $6K |
| Dec 22, 2023 | McKee Kelly T. Jr. | Chief Medical Officer | Buy (P) | 7K | $2K |
| Sep 25, 2023 | McKee Kelly T. Jr. | Chief Medical Officer | Buy (P) | 10K | $5K |
Where institutional funds (13F), corporate insiders (Form 4) and US House members (STOCK Act) are buying or selling the same name in the same window. Green is buying, red is selling.
Insiders and Congress: last 180 days. Funds: latest 13F, top 100 holders incl. passive
| Source | Buying | Selling | Net |
|---|---|---|---|
13F funds Top 100 holders by value, passive included; the hero counts active managers only | 1 | 6 | – |
Insiders Form 4 open-market | 0 | 0 | $0 |
US House STOCK Act trades | 0 | 0 | $0 |
Capital Rotation reports where institutional capital disclosed rotating, as of the latest public SEC 13F filings. It is data, not investment advice, a recommendation, or a prediction. Filings lag about 45 days and cover long US equity positions only. Past disclosed flows do not indicate future prices. Do your own research; consult a licensed advisor.
Connected entities for GOVX
This stock page is the public Follow view. For one current, evidence-backed answer, use capital_change_brief through REST or MCP. It compares tracked 13F changes with qualifying Form 4 activity and cites the SEC evidence.
curl -H "Authorization: Bearer YOUR_API_KEY" \ "https://arkolith.com/api/v1/stocks/GOVX/capital-change-brief"
Use Arkolith's capital_change_brief for GOVX. Tell me what changed, whether insider activity corroborates it, and cite the SEC evidence.
13F holdings + Form 4 insider transactions + end-of-day price history + the live filing stream, joined for GOVX. Filings are public domain, sourced to SEC EDGAR; price series derived from end-of-day closes.